Abstract

Objective: Children with congenital heart disease are at risk of malnutrition due to inadequate calorie intake, increased energy expenditure, pulmonary infections, and malabsorption. The aim of this study was to investigate the changes in appetite, nutritional hormones, and anthropometric measurements before and after the transcatheter closure of the atrial septal defect.

Method: The study included 27 patients whose atrial septal defect closed percutaneously and 25 children as a healthy control group. The initial symptoms, anthropometric measurements, and laboratory tests were recorded initially, and 1 month and 6 months after the closure.

Results: The mean age of patients and control group were 88.29 ± 58.25 months, 86.52 ± 55.81 months respectively. At the 1st month after the closure, all the symptoms in the patient group decreased compared to the initial visit except rapid breathing (p <0.05). The percentage of patients who had a lack of appetite decreased from 45% to 5% at the 1st month visit. After the closure, the increase in weight for age, body mass index, and z-score were statistically significant at the 1st and 6th months (p <0.05). Insulin-like growth factor-1 levels increased compared to the initial values at the 1st month (p =0.016). A linear decrease in ghrelin levels and a linear increase in leptin levels were observed in the atrial septal defect group during the 6-month follow-up after the closure.

Conclusion: Children with atrial septal defect are at the risk of malnutrition. The primary prevention of malnutrition should be the goal of our treatment plan for these children; the timing of the interventional treatment is critical and has to be before the development of malnutrition.

Keywords: Atrial septal defect, children, ghrelin, growth, leptin, nutrition

Copyright and license

Copyright © 2023 The author(s). This is an open-access article published by Aydın Pediatric Society under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Taşcı O, Pamukçu Ö, Narin N, Barlak Keti D, Sunkak S, Vural Ç, et al. The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. Trends in Pediatrics. 2023;4(1):6-13. https://doi.org/10.59213/TP.2023.55265

References

  1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-60. https://doi.org/10.1038/45230
  2. Kimura D, McNamara IF, Wang J, Fowke JH, West AN, Philip R. Pulmonary hypertension during respiratory syncytial virus bronchiolitis: a risk factor for severity of illness. Cardiol Young. 2019;29:615-9. https://doi.org/10.1017/S1047951119000313
  3. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255-61. https://doi.org/10.1210/endo.141.11.7757
  4. Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 2000;141:4325-8. https://doi.org/10.1210/endo.141.11.7873
  5. Mondal MS, Date Y, Yamaguchi H, et al. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul Pept. 2005;126:55-9. https://doi.org/10.1016/j.regpep.2004.08.038
  6. Kitamura T, Shimizu T, Ohkawa N, Oda H, Ohtsuki M, Kishiro M. Effects of ghrelin on growth and cardiac function in infants with congenital heart disease. Pediatr Int. 2010;52:358-61. https://doi.org/10.1111/j.1442-200X.2009.02966.x
  7. Toshinai K, Date Y, Murakami N, et al. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology. 2003;144:1506-12. https://doi.org/10.1210/en.2002-220788
  8. Kandil ME, Elwan A, Hussein Y, Kandeel W, Rasheed M. Ghrelin levels in children with congenital heart disease. J Trop Pediatr. 2009;55:307-12. https://doi.org/10.1093/tropej/fmp012
  9. Nagaya N, Kojima M, Uematsu M, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1483-7. https://doi.org/10.1152/ajpregu.2001.280.5.R1483
  10. Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 2001;104:2034-8. https://doi.org/10.1161/hc4201.097836
  11. Toth MJ, Gottlieb SS, Fisher ML, Ryan AS, Nicklas BJ, Poehlman ET. Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism. 1997;46:450-3. https://doi.org/10.1016/s0026-0495(97)90065-2
  12. Barton JS, Hindmarsh PC, Preece MA. Serum insulin-like growth factor 1 in congenital heart disease. Arch Dis Child. 1996;75:162-3. https://doi.org/10.1136/adc.75.2.162
  13. Kerpel-Fronius E, Kiss S, Kardos G, Gács G. Somatomedin and growth hormone in patients with retarded growth and atrophy due to congenital heart disease or malabsorption. Monatsschr Kinderheilkd (1902). 1977;125:783-6.
  14. Yılmaz R, Esmeray H, Erkorkmaz Ü. Adaptation study of the Turkish Children's Eating Behavior Questionnaire. Alpha Psychiatry. 2011;12:287-94.
  15. Guven B, Can M, Mungan G, Acіkgoz S. Reference values for serum levels of insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP-3) in the West Black Sea region of Turkey. Scand J Clin Lab Invest. 2013;73:135-40. https://doi.org/10.3109/00365513.2012.755739
  16. Knop MT, Białkowski J, Szkutnik M, et al. Transcatheter closure of atrial septal defects type 2 in children under three years of age. Kardiol Pol. 2018;76:1257-62. https://doi.org/10.5603/KP.a2018.0113
  17. Sharma B, Pinto R, Dalvi B. Transcatheter closure of atrial septal defect in symptomatic children weighing ≤10 kg: Addressing unanswered issues from a decade of experience. Ann Pediatr Cardiol. 2020;13:4-10. https://doi.org/10.4103/apc.APC_66_19
  18. Narin N, Baspinar O, Pamukcu O, et al. Percutaneous ASD closure of children weighing less than 10 kg. Acta Cardiol. 2020;75:631-6. https://doi.org/10.1080/00015385.2019.1648711
  19. Mehrizi A, Drash A. Growth disturbance in congenital heart disease. J Pediatr. 1962;61:418-29. https://doi.org/10.1016/s0022-3476(62)80373-4
  20. Yilmaz E, Ustundag B, Sen Y, Akarsu S, Citak Kurt AN, Dogan Y. The levels of Ghrelin, TNF-alpha, and IL-6 in children with cyanotic and acyanotic congenital heart disease. Mediators Inflamm. 2007;2007:32403. https://doi.org/10.1155/2007/32403
  21. Blasquez A, Clouzeau H, Fayon M, et al. Evaluation of nutritional status and support in children with congenital heart disease. Eur J Clin Nutr. 2016;70:528-31. https://doi.org/10.1038/ejcn.2015.209
  22. Soliman AT, Elawwa A, Khella A, Saeed S, Yassin H. Linear growth in relation to the circulating concentration of insulin-like growth factor-I in young children with acyanotic congenital heart disease with left to right shunts before versus after surgical intervention. Indian J Endocrinol Metab. 2012;16:791-5. https://doi.org/10.4103/2230-8210.100678
  23. Surmeli-Onay O, Cindik N, Tulgar Kinik S, Ozkan S, Bayraktar N, Tokel K. The effect of corrective surgery on serum IGF-1, IGFBP-3 levels and growth in children with congenital heart disease. J Pediatr Endocrinol Metab. 2011;24:483-7. https://doi.org/10.1515/jpem.2011.061
  24. Hallioglu O, Alehan D, Kandemir N. Plasma leptin levels in children with cyanotic and acyanotic congenital heart disease and correlations with growth parameters. Int J Cardiol. 2003;92:93-7. https://doi.org/10.1016/s0167-5273(03)00044-5